Blood Iron Test Predicts Fatal Outcomes
|
By LabMedica International staff writers Posted on 14 Apr 2014 |

Image: The Coulter Electronic Counter (Photo courtesy of Beckman Coulter).
The transferrin saturation (TSAT) ratio is a commonly used indicator of iron deficiency and iron overload in clinical practice, but precise relationships with total and cardiovascular mortality are equivocal.
The test is a measure of the amount of available iron in the bloodstream with low levels generally reflecting a state of iron deficiency and high levels suggesting a relative excess which can be detrimental to health.
Scientists at the University of Limerick (Ireland) studied 15,823 participants, 20 years of age or older, who had a valid serum creatinine value. Serum creatinine values were used to determine the estimated glomerular filtration rate (eGFR) in mL/min/1.73 m2 for all participants. Blood samples were obtained from nonfasting persons and frozen serum sent for analysis.
Serum iron and total iron binding capacity were measured colorimetrically (Alpkem RFA analyzer; Clackamas, OR, USA), and serum ferritin was measured with the Quantimmune IRMA kit (Bio-Rad Laboratories; Hercules, CA, USA). Hemoglobin was measured using a Coulter S-Plus Jr electronic counter (Coulter Electronics; Hialeah, FL, USA). Serum creatinine concentrations were measured by the modified kinetic Jaffe reaction using a Hitachi 737 analyzer (Boehringer Mannheim Corp.; Indianapolis, IN, USA).
The study found that subjects with extremely low transferrin saturation levels of less that 17.5% were at a 45% higher risk of death. On the other hand, the risk of death was also significantly higher for subjects with very high levels of transferrin saturation above 31.3 %. The mean values for TSAT were 26.3 %; hemoglobin 14.2 g/dL and serum ferritin level 129 ng/mL. The association of TSAT with mortality differed by race and sex. Among whites and blacks, low and high TSAT levels were associated with higher mortality risk while no association was manifest in Mexican-Americans. For men, the impact on mortality was demonstrated only in older males, while for women the j-shaped mortality association was confined to younger females. High levels usually occur in states of iron overload like hemochromatosis, multiple blood transfusions and cirrhosis.
Austin G. Stack MD MSc, a professor and senior author of the study said, “Our analysis suggests that the optimal transferrin saturation range for patient survival should be between 23% to 40% and that careful clinical assessment is warranted for patients with low and high levels in order to identify states of iron deficiency or iron excess. Our study demonstrates that transferrin saturation ratio is a useful prognostic tool in assessing a patient's health and while we support the correction of low transferrin saturation levels in the general population, we would also advise caution against excessive iron loading to levels beyond 40%.” The study was published on March 5, 2014, in the Quarterly Journal of Medicine.
Related Links:
University of Limerick
Alpkem
Bio-Rad
The test is a measure of the amount of available iron in the bloodstream with low levels generally reflecting a state of iron deficiency and high levels suggesting a relative excess which can be detrimental to health.
Scientists at the University of Limerick (Ireland) studied 15,823 participants, 20 years of age or older, who had a valid serum creatinine value. Serum creatinine values were used to determine the estimated glomerular filtration rate (eGFR) in mL/min/1.73 m2 for all participants. Blood samples were obtained from nonfasting persons and frozen serum sent for analysis.
Serum iron and total iron binding capacity were measured colorimetrically (Alpkem RFA analyzer; Clackamas, OR, USA), and serum ferritin was measured with the Quantimmune IRMA kit (Bio-Rad Laboratories; Hercules, CA, USA). Hemoglobin was measured using a Coulter S-Plus Jr electronic counter (Coulter Electronics; Hialeah, FL, USA). Serum creatinine concentrations were measured by the modified kinetic Jaffe reaction using a Hitachi 737 analyzer (Boehringer Mannheim Corp.; Indianapolis, IN, USA).
The study found that subjects with extremely low transferrin saturation levels of less that 17.5% were at a 45% higher risk of death. On the other hand, the risk of death was also significantly higher for subjects with very high levels of transferrin saturation above 31.3 %. The mean values for TSAT were 26.3 %; hemoglobin 14.2 g/dL and serum ferritin level 129 ng/mL. The association of TSAT with mortality differed by race and sex. Among whites and blacks, low and high TSAT levels were associated with higher mortality risk while no association was manifest in Mexican-Americans. For men, the impact on mortality was demonstrated only in older males, while for women the j-shaped mortality association was confined to younger females. High levels usually occur in states of iron overload like hemochromatosis, multiple blood transfusions and cirrhosis.
Austin G. Stack MD MSc, a professor and senior author of the study said, “Our analysis suggests that the optimal transferrin saturation range for patient survival should be between 23% to 40% and that careful clinical assessment is warranted for patients with low and high levels in order to identify states of iron deficiency or iron excess. Our study demonstrates that transferrin saturation ratio is a useful prognostic tool in assessing a patient's health and while we support the correction of low transferrin saturation levels in the general population, we would also advise caution against excessive iron loading to levels beyond 40%.” The study was published on March 5, 2014, in the Quarterly Journal of Medicine.
Related Links:
University of Limerick
Alpkem
Bio-Rad
Latest Clinical Chem. News
- Urine-Based Nanosensor Tracks Lung Cancer and Fibrosis Noninvasively
- FDA-Cleared Assay Enables Comprehensive Automated Testosterone Testing
- CE-Marked Blood Biomarker Test Advances Automated Alzheimer’s Diagnostics
- Blood-Based Alzheimer’s Test Gains CE Mark for Amyloid Pathology Detection
- Noninvasive Urine Test May Support Earlier Diagnosis of Psychiatric Disorders
- At-Home Blood and Cognitive Tests Support Dementia Risk Stratification
- Ultrasensitive Test Detects Key Biomarker of Frontotemporal Dementia Subtype
- Routine Blood Tests Years Before Pregnancy Could Identify Preeclampsia Risk
- Blood Test Detects Testicular Cancer Missed by Standard Markers
- Routine Blood Tests Identify Biomarkers Linked to PTSD
- Proteomic Data Underscore Need for Age-Specific Pediatric Reference Ranges
- Routine Blood Count Ratio Linked to Future Alzheimer’s and Dementia Risk
- Label-Free Microfluidic Device Enriches Tumor Cells and Clusters from Pleural Effusions
- Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection
- Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation
- Blood Test Predicts Alzheimer Disease Risk Before Imaging Changes and Symptoms
Channels
Molecular Diagnostics
view channel
Breast Cancer-Specific Signatures Link Genome Instability to Outcomes
Genomic instability is a hallmark of cancer, but most genomic analyses have relied on broad signatures shared across multiple malignancies, limiting their precision for individual tumor types.... Read more
Whole-Genome MRD Test Detects Early Recurrence in Muscle-Invasive Bladder Cancer
Bladder cancer is among the most common malignancies in the United States, with about 85,000 new cases each year. The muscle-invasive form accounts for roughly one quarter of diagnoses and carries a high... Read more
Blood Test Detects Early Nonresponse in Metastatic Prostate Cancer
Prostate cancer is the most common cancer in the U.K., with more than 64,000 men diagnosed and 12,000 deaths each year. For the roughly 10,000 men annually with advanced disease, early assessment of treatment... Read more
FDA-Cleared Genomic Profiling Assay Guides Treatment Selection in Solid Tumors
Datar Cancer Genetics (DCG; Nashik, India), a global precision oncology company, has announced that its tissue-based comprehensive genomic profiling (CGP) assay for all solid tumors, CellDx-Tissue, has received U.... Read moreHematology
view channel
Stem Cell Biomarkers May Guide Precision Treatment in Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is an aggressive blood cancer that most often affects older adults and still carries a poor prognosis despite therapeutic advances. Venetoclax-based regimens have improved... Read more
Advanced CBC-Derived Indices Integrated into Hematology Platforms
Diatron, a STRATEC brand, has introduced six advanced hematological indices on its Aquila, Aquarius 3, and Abacus 5 hematology analyzers. The new Research Use Only (RUO) indices include Neutrophil-to-Lymphocyte... Read moreImmunology
view channel
Routine TB Screening Test May Reveal Immune Aging and Mortality Risk
Immune aging is associated with weaker responses to vaccination, greater risks of infection, and higher levels of inflammation. Leveraging routinely ordered laboratory tests to quantify that responsiveness... Read more
Biomarkers and Molecular Testing Advance Precision Allergy Care
Allergic diseases often present with similar symptoms but can be driven by distinct biological mechanisms, making standardized care inefficient for many patients. Historically, individuals with pollen... Read moreMicrobiology
view channel
Study Finds Hidden Mpox Infections May Drive Ongoing Spread
Mpox continues to circulate despite vaccination, and many cases show no known link to a symptomatic partner. The role of people without symptoms has remained uncertain, limiting clarity on how transmission persists.... Read more
Large-Scale Genomic Surveillance Tracks Resistant Bacteria Across European Hospitals
Antimicrobial resistance (AMR) poses a growing threat to patient safety, with carbapenem-resistant Enterobacterales causing difficult-to-treat infections and leaving clinicians with limited therapeutic options.... Read more
Molecular Urine and Stool Tests Do Not Improve Early TB Treatment in Hospitalized HIV Patients
Tuberculosis is the leading cause of death among people living with HIV, and diagnosis in hospital settings remains difficult. Symptoms are often non-specific, disease can be extrapulmonary, and many patients... Read morePathology
view channel
Rapid AI Tool Predicts Cancer Spatial Gene Expression from Pathology Images
Gene expression profiling can inform tumor biology and treatment selection, but spatial assays remain costly and time-consuming. Results can take weeks and cost thousands of dollars, limiting large-scale... Read more
AI Pathology Test Receives FDA Breakthrough for Bladder Cancer Risk Stratification
Non–muscle invasive bladder cancer has highly variable outcomes, complicating surveillance and treatment planning. Risk assessment typically relies on stage, grade, and tumor size, leaving uncertainty... Read moreTechnology
view channel
Point-of-Care Testing Enhances Health Literacy and Self-Management in Chronic Disease
Limited access to general practitioners and pathology services can delay diagnosis and monitoring for people in regional and remote communities. Rapid, on-the-spot testing can shorten turnaround times... Read more
Fully Automated Sample-to-Insight Workflow Advances Latent TB Testing
Latent tuberculosis remains a substantial testing workload for clinical laboratories as screening programs expand. Despite this growth, only about 40% of testing has shifted from traditional skin tests... Read moreIndustry
view channel
AI-Powered Multi-Functional Analyzer Wins German Innovation Award
Hematology services are increasingly delivered across distributed care settings, where limited staffing and complex workflows can extend turnaround times. Advanced morphology review still often depends... Read more








